Hydrogel Nanocompsites for Ophthalmic Applications
The present invention relates to reversible hydrogel systems. Particularly, the hydrogel of the present invention is made up of copolymers that can be a hydrogel when in an oxidized state and can be a solution when in a reduced state. A solution of the copolymer can be oxidized to form a hydrogel; and the hydrogel can be reduced to form a solution of the copolymer. Reversible nanogels can also be formed from a dilute solution of the copolymers. The hydrogel is formed with nanoparticles embedded therein to form a nanocomposite whose refractive index and modulus can be controlled by varying the amounts of nanoparticles and the polymer concentration of the hydrogel, respectively
-
Page/Page column 5-6
(2010/11/29)
Chitosan-psyllium complexes and methods for making and using same
A composition comprising a chitosan-psyllium complex that was prepared by a solid-state enzymatic reaction. The composition can be used to reduce plasma cholesterol levels as well as fat absorption. Thus, a variety of products and methods can be used and/or developed with the composition.
-
Page/Page column 2; 3
(2010/02/12)
N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
Disclosed are compounds which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
Page/Page column 30
(2010/02/11)
More Articles about upstream products of 148465-45-6